Skip to content

Effects of progressive muscle relaxation training combined with energy conservation management on fatigue, quality of life and self-management efficacy in postoperative chemotherapy patients with breast cancer

Effects of progressive muscle relaxation training combined with energy conservation management on fatigue, quality of life and self-management efficacy in postoperative chemotherapy patients with breast cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078847
Enrollment
Unknown
Registered
2023-12-20
Start date
2023-12-20
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

group 1:Energy conversation management patient education
group 2:Energy conversation management combined with progressive muscle relaxation training patient education
group 3:Routine care and patient education

Sponsors

Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ?Patient age = 18 years old ? The patient is diagnosed with breast cancer stage I, II, or IIIa (non-metastatic) by pathologic examination ?The patient has been treated with mastectomy for breast cancer (more than 3 weeks) ? Hospitalized patients who will start postoperative adjuvant chemotherapy within 1 week, with a chemotherapy cycle of 21 days ? Patients do not have hearing and speech disorders, have the ability to understand and speak Mandarin or Teochew, and have clear language expression (6) Patients are willing to participate in the study and sign an informed consent form. (7) Patients or their family members are able to use smart phones on their own.

Exclusion criteria

Exclusion criteria: ?Patients who are currently taking central stimulants, antidepressants, or Chinese medicines or proprietary Chinese medicines for fatigue; ? Patients with combined serious heart, brain, kidney and other organ dysfunction; ? Patients with cognitive impairment and/or severe mental illness; ? Patients with hemoglobin level lower than 110g/L or have been treated for anemia within 1 month; ? Patients are participating in other clinical studies; (6) Concurrent chemotherapy and radiotherapy.

Design outcomes

Primary

MeasureTime frame
Cancer fatigue scale;Functional Assessment of Cancer Therapy-Breast;Chinese-version Strategies Used by People to Promote Health,C-SUPHH;

Countries

China

Contacts

Public ContactSu Jing

Shantou University Medical College

jsu@stu.edu.cn+86 150 1880 3029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026